Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102260244B details a stable rabeprazole sodium synthesis with 99.9% purity. Offers superior moisture stability and cost-effective manufacturing for global supply chains.
Novel synthesis route for chiral pyrrolo-pyridine intermediates offers high purity and scalability. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Advanced biocatalytic synthesis of betulinic acid using ionic liquids. Enhances yield and supply chain reliability for pharmaceutical intermediates.
Patent CN104892623B enables high-purity 5-ISMN production. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.
Patent CN102226213B details enzymatic betulinic acid production. Offers safe, scalable pharmaceutical intermediate manufacturing with reduced environmental impact.
Explore CN115043784B patent technology for high-purity biphenyl-1,2,3-triazole synthesis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable click chemistry.
Patent CN104844514B discloses novel diarylpyrazole derivatives with potent androgen receptor antagonism. Explore scalable synthesis and supply chain advantages for pharmaceutical intermediates.
Patent CN101891797A reveals a selective hydrolysis method for steroidal 17α-esters, offering superior yield and purity for pharmaceutical manufacturing supply chains.
Patent CN106083813A details a mild CuAAC route for triazole-quinolines. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN103772276B reveals an eco-friendly synthesis route for this aldose reductase inhibitor intermediate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102250076A reveals a mild, high-yield route for Rivaroxaban intermediates using magnesium halides, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN103694224A details a safer synthesis for fluorinated dabigatran analogs. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103694225A reveals a stable titanium catalyst ligand for high-yield dexlansoprazole synthesis, offering significant cost reduction and supply reliability for API manufacturing.
Metal-free Brønsted acid catalyzed synthesis of trans-3,4-diaryl dihydrocoumarins with high diastereoselectivity. Ideal for scalable API intermediate manufacturing.
Patent CN100509799C details a high-yield synthesis of antithrombin inhibitors. Discover cost reduction in pharmaceutical intermediate manufacturing and supply chain advantages.
Novel two-step synthesis for posaconazole intermediate offers high purity and reduced costs. Reliable pharma intermediate supplier for scalable production.
Patent CN100369872C reveals a mild aqueous hydrogenation method for biotin intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN119591507B reveals a novel photocatalytic route for gem-difluorocyclopentane. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity supply.
Patent CN104910047A reveals efficient synthesis route. Reduces cost and complexity for API manufacturing. Ensures high purity and supply continuity.